Cart summary

You have no items in your shopping cart.

Denecimig Antibody

SKU: orb1942185

Description

Denecimig (Mim8) is a humanized bispecific IgG4κ antibody that mimics activated factor VIII function, promoting FIXa and FX assembly to enhance thrombin generation and hemostasis. It is applied in preclinical research for hemophilia A, including studies in relevant in vitro assays and in vivo bleeding models.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number2488745-86-2
Purity95.00%
TargetFactor Xa,Factor VIII

Bioactivity

In Vivo
I the toxicity study of Denecimig using monkeys as subjects, intravenous or subcutaneous administration (0.3–60 mg/kg/week) was employed the Results showed that Denecimig (0.3–3 mg/kg/week, subcutaneous injection) did not induce significant clinical symptoms, excessive coagulation, or pathological changes. however, whe the dose was increased to 6–20 mg/kg/week, 16% o the animals exhibited thrombosis-related pathological change.
In Vitro
In a study of hemostatic activity in blood Samples from hemophilia patients, both Thrombin Generation Assay (TGA) and Thromboelastography (TEG) were used for evaluation. TGA was performed using PPP-low reagent and PRP reagent. Whole blood Samples were analyzed wit the ROTEMdelta device for NATEM analysis, providing a comprehensive assessment o the coagulation status the study also evaluate the effects of Denecimig when used in combination with recombinant FVIII (100 IU/dL), recombinant FVIIa (25 mM), and APCC (20 and 30 U/kg) the in vitro Results showed that Denecimig significantly enhanced thrombin generation in severe hemophilia A patients, with its procoagulant effect comparable to 100 IU/dL of FVIII. Further research found that when Denecimig was used in combination with rFVIIa (90 µg/kg), it did not induce a hypercoagulable state. however, when Denecimig was combined with APCC, it could significantly increas the risk of hypercoagulation.

Storage & Handling

StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
DisclaimerFor research use only

Alternative Names

Mim8, Factor Xa, FactorXa

Similar Products

  • Denecimig Human Monoclonal Antibody [orb2977150]

    ELISA,  FA,  FACS,  In vivo

    Human

    Human

    Monoclonal

    Unconjugated

    1 mg, 100 μg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Denecimig Antibody (orb1942185)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 370.00
5 mg
$ 910.00
10 mg
$ 1,270.00
25 mg
$ 1,860.00
DispatchUsually dispatched over 10 weeks
Bulk Enquiry